Healthy men needed to test two versions of prostate drug
NCT ID NCT07103278
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This early-stage study will compare two formulations of a drug for benign prostatic hyperplasia (enlarged prostate) in 44 healthy adult male volunteers. Participants will receive a single dose of each version under fasting conditions to measure safety and how the drug moves through the body. The goal is to see if the two formulations behave similarly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.